Viewing Study NCT03096834


Ignite Creation Date: 2025-12-25 @ 2:26 AM
Ignite Modification Date: 2026-05-17 @ 5:08 PM
Study NCT ID: NCT03096834
Status: COMPLETED
Last Update Posted: 2022-03-23
First Post: 2017-03-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CAMG334A2301
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators